Duraphat

Quick links to important sections

Duraphat

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Duraphat

Quick Facts

Property Description
Active ingredient Sodium Fluoride (Fluoride ion)
Form High-Concentration Toothpaste; Dental Suspension (Varnish)
Pharmacological class Caries Preventing Agent; Topical Fluoride Agent
Common use Prevention of dental caries and relief of dentine hypersensitivity
Origin Synthetic (Inorganic salt derived product)

Duraphat: Definition and Classification as a Caries Preventing Agent

Duraphat is a high-strength, prescription-only medicinal product whose active agent is Sodium Fluoride, primarily classified as a caries preventing agent within the therapeutic group of topical fluoride agents. The product is a synthetic compound that is distinct from standard fluoride formulations due to its significantly higher concentration. This high-strength preparation serves as a tool in offsetting the risk of dental decay, particularly for patients with compromised dental health or those at a high risk of developing multiple caries.

Composition and Forms of High-Strength Sodium Fluoride

The essential active ingredient is Sodium Fluoride, which acts as the source for the therapeutically active fluoride ion. The medicine is supplied in two distinctive dosage form(s): a specialized high-concentration toothpaste for patient self-application and a liquid dental suspension that is designed for professional application. This suspension is engineered to form an adhesive film, often known as a dental varnish, upon contact with the tooth surface, ensuring prolonged local exposure to the fluoride. This localized, topical route of administration allows for optimal delivery of the active substance to the enamel and dentine.

Primary Purpose: Enamel Reinforcement and Sensitivity Relief

The general purpose of Duraphat is to provide active defense against dental caries (tooth decay) through substantial mineral reinforcement of the tooth structure. The high dose of fluoride ion promotes remineralisation and creates a robust surface barrier, inhibiting acid damage. Furthermore, the product functions to provide relief from dentine hypersensitivity (sensitive teeth). The varnish formulation provides occlusion of dentinal tubules, which is the mechanism used to reduce the transmission of painful external stimuli.

What side effects are possible with Duraphat?

Duraphat: Possible Side Effects and Safety Information

Adverse Reactions

Side effects associated with Duraphat are generally infrequent. The most commonly documented adverse reactions include hypersensitivity reactions (allergic reactions), which are classified as rare (affecting less than 1 in 1,000 users). These may involve symptoms such as rash, itching, swelling, or redness. Additionally, a burning oral sensation has been reported with a frequency classified as not known.

Adverse Reaction Category Frequency Classification Examples of Symptoms
Hypersensitivity Reactions Rare (<1/1,000) Rash, itching, swelling, redness
Gastrointestinal/Local Frequency not known Burning oral sensation

Acute and Chronic Toxicity

Safety concerns are primarily related to excessive fluoride exposure, particularly through accidental ingestion. The estimated toxic dose (lowest dose at which symptoms of intoxication can occur) is documented as 5 mg fluoride per kilogram of body weight. Acute ingestion of a substantial amount may lead to severe gastrointestinal effects, including vomiting, diarrhea, and abdominal pain. In extremely rare instances, acute toxicity can be fatal. Long-term, chronic ingestion of excessive fluoride (typically >1.5 mg daily over months or years) can result in dental fluorosis (stained or speckled enamel) or bone fluorosis (osteosclerosis, or increased bone density).

Safety Restrictions and Precautions

  • Contraindications: Duraphat is contraindicated in individuals with known hypersensitivity to sodium fluoride or any of the excipients.
  • Age Restriction: The toothpaste formulation is strictly for use by individuals aged 16 years and over.
  • Other Fluoride Sources: Due to the high fluoride content, the use of other high-dose fluoride preparations (e.g., tablets, gels, mouthwashes, fluoridated water/salt) must be avoided during treatment to prevent accumulation. An assessment of overall fluoride intake is necessary prior to use.
  • Excipient Warnings: Contains sodium benzoate, which may cause local irritation. Ingesting excessive amounts of the excipient menthol may lead to convulsions, particularly in infants and children.
  • Pregnancy/Lactation: Use during pregnancy or lactation is generally not recommended unless a careful risk-benefit assessment by a healthcare professional has been conducted, due to insufficient human data.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents detail the required response and clinical profile for high-concentration sodium fluoride overdose. Acute intoxication is initially characterized by severe gastrointestinal distress, including vomiting, diarrhoea, abdominal pain, salivation, and a burning sensation in the mouth or sore tongue. The official lowest dose documented to induce these acute intoxication symptoms is 5 mg fluoride per kg body weight.


Emergency Actions and Severe Outcomes

Immediate medical assistance is required upon the accidental consumption of a substantial quantity. Ingestion exceeding the established threshold of 15 mg fluoride per kg body weight mandates immediate hospital admission. Severe outcomes may include haematemesis (bloody vomit) and, particularly in infants and children, convulsions; extremely rare fatal outcomes have been noted in cases of high acute ingestion.

Supportive care is the primary treatment approach, as no specific antidote is documented. Initial management may include immediate gastric lavage or induced vomiting, if medically appropriate, along with the oral administration of calcium, such as a large amount of milk, to relieve gastrointestinal symptoms. Following management, the patient must remain under medical observation for several hours.


Population and Chronic Risk

Infants and children are the population most susceptible to severe acute intoxication. For long-term exposure, chronic overdose is officially associated with the development of fluorosis, manifesting as either dental fluorosis (mottled enamel) or skeletal fluorosis (osteosclerosis) resulting from prolonged excessive systemic absorption.

Therapeutic Uses of Duraphat

What Duraphat Treats: Main Uses and Benefits

Duraphat is a topical treatment commonly used across conditions presenting with acute episodes where additional symptomatic support is needed. It is primarily used in the therapeutic domain of dental health to manage symptoms that create noticeable physiological strain and discomfort.

Therapeutic applications of this treatment include caries prevention and the desensitisation of sensitive teeth. The compound supports the tooth's functional stability and is applied in addressing sensitive teeth, which contributes to improved comfort during periods of heightened symptoms. This makes it relevant where supportive symptom management is applied for symptoms related to physical discomfort and to assist with maintaining functional stability.

Its primary uses are to help manage the symptoms associated with dental decay and to provide support for dentinal hypersensitivity. The use of this treatment helps ease the overall symptom burden in situations where symptoms interfere with daily functioning.

Quick Fact: Supports patients during periods of Heightened Symptoms

Regulatory References

  1. New Zealand Data Sheet on Duraphat Fluoride Varnish

Eligibility and Restrictions for Use

Who Can and Cannot Use Duraphat? – Official Eligibility Rules

Regulatory documents establish strict eligibility criteria for Duraphat based on the formulation (toothpaste or varnish) and concentration, defining populations for whom use is contraindicated, restricted, or allowed.


Populations Contraindicated

Use is strictly prohibited in patients with:

  • Known hypersensitivity to sodium fluoride or any excipients.
  • For the Varnish/Suspension form, patients with ulcerative gingivitis, stomatitis, or bronchial asthma.
  • For certain Toothpaste formulations, patients with rare hereditary fructose intolerance.

Age-Related Eligibility

The approved minimum age varies by product concentration:

  • 5000 ppm Toothpaste: Contraindicated for individuals under 16 years of age.
  • 2800 ppm Toothpaste: Contraindicated for children under 10 years of age.

Use Restrictions (Pregnancy and Lactation)

  • 2800 ppm Toothpaste may be used during pregnancy and lactation.
  • 5000 ppm Toothpaste and the Varnish/Suspension are not recommended during pregnancy or lactation unless a professional risk-benefit assessment is conducted, citing a lack of adequate data or specific excipient content.

Conditional Use Requirements

All use requires an assessment of the patient's total fluoride intake from all sources to mitigate the risk of fluoride accumulation. The application of the dental varnish should also not be done on an empty stomach.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents indicate that high-concentration Sodium Fluoride (Duraphat) has a minimal drug-drug interaction profile due to its topical route of administration and limited systemic absorption. The primary concern is a pharmacodynamic interaction related to the total amount of fluoride consumed from all sources.

Interaction Scope

Category Official Regulatory Information
Interacting Substances Other high-dose fluoride preparations, including fluoride gels, tablets, drops, and chewing gums.
Mechanistic Basis Pharmacodynamic Accumulation Risk: Co-administration results in an additive increase in systemic fluoride exposure, raising the documented risk of fluorosis.
Timing-based Rules Fluoride supplements must be suspended for several days following the professional application of the varnish formulation. Avoid food and drink immediately after use to prevent an inhibitory effect on remineralisation.
Substance Interaction Note The Dental Suspension (Varnish) contains ethanol (alcohol, 33.8% v/v), a factor to be considered.
Population Note Due to the alcohol content in the Varnish formula, regulatory guidance recommends avoidance in pregnant women and during lactation.

Interaction Classifications (High-Level)

Official regulatory sources explicitly state that no pharmacokinetic interactions with other medicines are known (e.g., those involving CYP enzymes). Mandatory assessment of a patient’s total daily intake of fluoride from all sources, including fluoridated water or salt, is an essential constraint defined in the prescribing information.

Mechanism of Action

Duraphat acts by delivering a high concentration of fluoride ions to the enamel surface, which is the primary biological target. The fluoride ions rapidly incorporate into the hydroxyapatite crystal lattice ( Ca5( PO4)3( OH)), substituting hydroxyl groups to form fluorapatite ( Ca5( PO4)3 F). Fluorapatite is chemically distinct and inherently less acid-soluble than native hydroxyapatite, altering the critical mineral composition of the enamel. This change accelerates the tooth's natural remineralization process by modulating the dissolution/reprecipitation cycle on the tooth surface. The presence of fluoride ions also temporarily inhibits specific Mg^2+- and Ca^2+-dependent enzymes, further influencing the demineralization cascade. This cumulative chemical alteration influences the overall structural integrity and surface chemistry of the enamel.

Dosage and Administration Information

Administration and Usage

Duraphat 50 mg/mL Dental Suspension is a medicinal product for topical application to the teeth and is administered by a dental professional, rather than for patient self-medication.

Administration Procedure

To facilitate the application process, the dental professional removes excess dental plaque and dries the teeth prior to application. The suspension is applied as a thin layer to the surfaces susceptible to caries using a brush, probe, or applicator. It is a technique used to begin application on the lower jaw to manage saliva accumulation.

Dosing Schedule and Frequency

The maximum dose per single application varies based on the patient's dentition and age-group. The suspension is typically applied to the dentition after the patient has eaten a meal.

Dentition Type Maximum Dose Per Application
Primary (Milk) Teeth Up to 0.25 mL (5.65 mg Fluoride)
Mixed Dentition Up to 0.40 mL (9.04 mg Fluoride)
Permanent Dentition Up to 0.75 mL (16.95 mg Fluoride)

For caries prevention, the application is typically repeated every six months, though a shorter interval of every three months is sometimes utilized. For the management of hypersensitivity, two or three applications are typically made within a few days.

Post-Application Instructions

Following treatment, patients are instructed not to brush their teeth or chew food for at least 4 hours to allow the varnish film to remain and exert its effect. Soft foods and liquids may be consumed during this period. Additionally, no other high-dose fluoride preparations, such as fluoride gels, are used on the day of application, and fluoride supplements are suspended for several days afterward.

Recent Clinical Evidence

Evidence for Use in Caries Prevention (Tooth Decay)

The evidence base for caries prevention was studied for primary and permanent teeth in extensive Systematic Reviews and Randomized Controlled Trials (RCTs). Research was conducted on broad populations of children and adolescents, and also examined its application in adults included in trials examining caries risk factors. These studies monitored caries increment (the change in decay over time). Findings describe patterns observed where measurements of caries increment were tracked in groups using the varnish compared to control groups over follow-up periods that typically ranged from one to five years.


Evidence for Use in Dentine Hypersensitivity (Sensitive Teeth)

The research for sensitive teeth was studied for short-term symptom changes mainly in RCTs. These trials explored changes by tracking patient-reported outcomes describing symptom intensity in adult patients. Findings describe patterns observed related to changes in sensitivity scores following application. The evidence is generally considered Moderate because the results apply only to the populations studied, and the follow-up durations were limited in many cases. Comparative evidence studies examined if the observed changes were similar to or different from those seen with other desensitizing agents.


Long-Term Studies and Follow-up Durability

The long-term patterns of using the varnish are monitored differently across its two main uses. For caries prevention, research includes studies with intermediate- to long-term follow-up extending to several years. However, for dentine hypersensitivity, long-term patterns are not fully established due to limited follow-up durations in many trials.


What Is Still Uncertain About Duraphat Research

A review of the evidence highlights several areas where certainty remains low. For caries prevention, the evidence quality varies across studies, meaning some systematic reviews described concerns about methodological differences. Regarding dentine hypersensitivity, data for certain groups remain insufficient alongside short follow-up durations and modest sample sizes. The research does not determine whether an individual will respond similarly; the findings describe group patterns, not personal outcomes.

Key Studies & References

  1. Treating cervical dentin hypersensitivity with fluoride varnish: a randomized clinical study.
  2. Topical Fluoride Clinical Practice Guideline (American Dental Association)
  3. Delivering Better Oral Health: An Evidence-Based Toolkit for Prevention - Chapter 9: Fluoride (UK Government Public Health Guidance)

Frequently Asked Questions (FAQ)

Common questions about Duraphat (FAQ)


Q: How quickly does Duraphat start working after application?

According to official product information, the varnish sets rapidly when it comes into contact with saliva. This fast setting allows the film to persist on the tooth surface for several hours, enabling the prolonged delivery and accumulation of fluoride ions into the tooth enamel.


Q: How long does the protective effect of Duraphat last?

For the prevention of dental caries (tooth decay), the official dosing schedule typically advises repeating the professional application every six months. In situations where a patient is considered to be at high risk, a dental professional may recommend a shorter interval, such as every three months.


Q: Is Duraphat used to treat cavities or just prevent them?

Duraphat is officially indicated for the prevention of dental caries (decay). However, official product information indicates that the product's strengthening mechanism—promoting remineralization—is relevant for early-stage carious lesions.


Q: Is it normal to feel a gritty or sticky feeling on the teeth right after the varnish is applied?

This sensation is a common occurrence. The product is a suspension that is painted onto the teeth and quickly forms a hardened varnish film on the tooth surface. This film is designed to persist for several hours and may be perceived as a sticky or coated feeling.


Q: Is it safe to use Duraphat if I have braces?

Official administration instructions address application around fixed orthodontic devices, such as braces, and specify that the varnish can be applied to these areas using specialized tools.


Q: What happens if I accidentally swallow some Duraphat during the application?

Since the application is carefully controlled by a dental professional, the total dose used in a single treatment is minimal. Regulatory information indicates that this dose is below the levels generally associated with signs of acute fluoride toxicity.


Q: Can Duraphat be used on exposed root surfaces?

Yes. The official application instructions mention that the varnish can be used to treat hypersensitive tooth necks, which includes exposed root surfaces, where it helps reduce sensitivity.


Q: Is it normal for my teeth to look slightly dull or yellowish right after the treatment?

This temporary color change is expected. The varnish has a yellowish color so the dental professional can easily see where it has been applied. The color and the varnish film will disappear when the varnish film is removed by brushing, which should only be done after the professional's recommended waiting period.


Q: Is there a special taste associated with Duraphat?

The varnish formulation contains menthol and may include other specific flavorings. These excipients are added to the product and contribute to the taste experienced during and shortly after the application.


Q: What interactions should I be aware of when using other medications?

Official regulatory documents state that no pharmacokinetic interactions with other medicines are known. The primary regulatory concern is a pharmacodynamic accumulation risk if other high-dose fluoride products are used simultaneously, which relates to the patient’s total fluoride exposure from all sources.


Q: What kind of professional studies support the use of Duraphat?

The product's efficacy is supported by high-quality professional studies, including Systematic Reviews and Randomized Controlled Trials (RCTs). These studies tracked the change in dental decay over time to confirm the patterns of use for caries prevention.


Q: Is there a risk of fluorosis from a Duraphat treatment?

The dosage for professional application is carefully controlled. Regulatory information indicates that this controlled, single dose is intended to mitigate the risk of chronic conditions, such as dental fluorosis, which are associated with long-term, excessive fluoride ingestion.


Q: What steps should I take before a Duraphat application?

Official instructions specify that patients are required to have eaten a meal before the varnish is applied to the entire dentition. Your dental professional will handle the required cleaning and drying of your teeth.


Q: How does the fluoride release from Duraphat happen over time?

The varnish film persists on the teeth for several hours. During this period, it provides a prolonged, slow release of fluoride, which enables the active ingredient to accumulate at a measurable depth in the tooth enamel.


Q: Can Duraphat be used if I have a filling or crown?

According to the official application instructions, the areas surrounding fillings and crowns can be treated in the same way as other parts of the tooth that are susceptible to decay or sensitivity.


Q: Why do some people experience temporary gum irritation after Duraphat?

Official documentation notes that one of the excipients, Sodium Benzoate, has the potential to cause local irritation of the mucous membrane, which may include the gums.


Q: What is the texture of the Duraphat varnish when it is first applied?

Duraphat is supplied as a liquid dental suspension. It is applied as a thin layer by the professional, which then quickly sets and hardens into an adhesive varnish film upon contact with the moisture in the mouth.


Q: How long does it take for the color of the varnish to disappear from the teeth?

The yellowish color and the varnish film will remain until removed by brushing. Official post-application rules state that brushing must be avoided for a specified duration (typically four hours), after which the varnish is removed during the patient's normal hygiene routine.


Q: Are there different flavors of Duraphat available?

The varnish formulation contains the excipient menthol, and it may include other flavorings. However, official regulatory documents do not specify or confirm that multiple flavor options are available for the dental suspension.

How should Duraphat be stored and disposed of?

Official Storage and Disposal Requirements

The storage and disposal of Duraphat (fluoride products) are governed by official regulatory requirements, focusing on temperature, flammability, stability, and child safety.

Requirement Area Official Guidelines
Temperature & Child Safety Store the medicine below 25 C and keep it strictly out of the reach and sight of children.
In-Use Stability The Dental Suspension (Varnish) must be used within 3 months after the tube is first opened, and high-concentration toothpastes within 6 months.
Handling (Dental Suspension) The Varnish must be stored away from heat, sparks, open flames, and all other ignition sources, as it contains ethanol. Containers must be tightly closed and stored in a well-ventilated, dry place.
Disposal Any unused product or waste material must be disposed of in accordance with local environmental and pharmaceutical waste regulations. The Dental Suspension must not be discharged into drains.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Duraphat found in:

A-Z Index: